Clinical TrialID 3744

N-methylglycine (Sarcosine) Treatment for Depression

NCT00977353

Major Depressive Disorder|Depression|Major Depression

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
3744
Evidence Id
3744
Core Evidence Id
3744
Source Clinical Trial Id
3717
Herb2 Clinical Trial Id
HBCT003717
Nct Id
NCT00977353
Title
N-methylglycine (Sarcosine) Treatment for Depression
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Major Depressive Disorder|Depression|Major Depression
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: citalopram|DRUG: sarcosine
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
40
Outcome Measure
17-item Hamilton Depression Rating Scale, score change, week 0, 2, 4, 6|Remission rate, week 0, 2,4, 6|GAF(Global Assessment of Function), score changes, Week 0, 2, 4, 6
Sponsor Collaborator
China Medical University Hospital|National Science Council, Taiwan
Funded By
OTHER
Location
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
Other Id
DOH95-TD-B-111-TM002
Start Date
2009-04
Primary Completion Date
2011-07
Completion Date
2011-07
First Posted
2009-09-15
Results First Posted
Last Update Posted
2011-07-12
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00977353
Title Cn
Title En
N-methylglycine (Sarcosine) Treatment for Depression
Bilingual Status
semi_complete